Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMETHEUS FRANCE : revenue, balance sheet and financial ratios
PHARMETHEUS FRANCE is a French company
founded 4 years ago,
specialized in the sector Activités spécialisées, scientifiques et techniques diverses.
Based in PUTEAUX (92800),
this company of category PME
shows in 2024 a net income positive of 107 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMETHEUS FRANCE (SIREN 907642011)
Indicator
2024
Revenue
N/C
Net income
107 355 €
EBITDA
N/C
Net margin
N/C
Revenue and income statement
In 2024, PHARMETHEUS FRANCE generates positive net income of 107 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
107 355 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.555%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.756%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
Debt ratio
1.555
Financial autonomy
41.756
Repayment capacity
None
Cash flow / Revenue
None%
Sector positioning
Debt ratio
1.552024
2024
Q1: 0.0
Med: 4.67
Q3: 40.89
Good
In 2024, the debt ratio of PHARMETHEUS FRANCE (1.55) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
41.76%2024
2024
Q1: 4.58%
Med: 32.74%
Q3: 63.16%
Good
In 2024, the financial autonomy of PHARMETHEUS FRANCE (41.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 166.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
166.099
Liquidity indicators evolution PHARMETHEUS FRANCE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
Liquidity ratio
166.099
Interest coverage
None
Sector positioning
Liquidity ratio
166.12024
2024
Q1: 144.63
Med: 259.05
Q3: 521.3
Average
In 2024, the liquidity ratio of PHARMETHEUS FRANCE (166.10) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMETHEUS FRANCE in its sector
Comparison with sector Activités spécialisées, scientifiques et techniques diverses
Valuation estimate
Based on 98 transactions of similar company sales
(all years),
the value of PHARMETHEUS FRANCE is estimated at
521 052 €
(range 104 910€ - 876 483€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
98 tx
104k€521k€876k€
521 052 €Range: 104 910€ - 876 483€
NAF 5 all-time
Valuation method used
Net Income Multiple
107 355 €
×
4.9x
=521 053 €
Range: 104 910€ - 876 483€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Activités spécialisées, scientifiques et techniques diverses)
Compare PHARMETHEUS FRANCE with other companies in the same sector:
Frequently asked questions about PHARMETHEUS FRANCE
What is the revenue of PHARMETHEUS FRANCE ?
The revenue of PHARMETHEUS FRANCE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMETHEUS FRANCE profitable?
Yes, PHARMETHEUS FRANCE generated a net profit of 107 k€ in 2024.
Where is the headquarters of PHARMETHEUS FRANCE ?
The headquarters of PHARMETHEUS FRANCE is located in PUTEAUX (92800), in the department Hauts-de-Seine.
Where to find the tax return of PHARMETHEUS FRANCE ?
The tax return of PHARMETHEUS FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMETHEUS FRANCE operate?
PHARMETHEUS FRANCE operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart